Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients

D. A. Revicki, K. Chan, F. Gevirtz

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus (HIV) infection results in a chronic course of disease progression and eventual death. With this disease progression comes decreases in health-related quality of life and cognitive function in many patients. We evaluated the construct and discriminant validity of the Medical Outcomes Study four-item and six-item cognitive function scale in a sample of 162 patients with HIV disease. The patients were assessed at baseline and after 4 months with the cognitive function scale, a cognitive functioning transition item, the Reitan trail making test (TMT) and the Centers for Epidemiologic Studies Depression (CES-D) scale. The results found that the four- and six-item cognitive function scales varied by HIV disease stage, CD4 count, self-reported change in cognitive function, TMT-based cognitive impairment and depression. The differences in the cognitive function scores were attenuated, but still remained statistically significant even after controlling for depression. The cognitive function scales predict cognitive impairment based on the TMT. The results support the construct validity of these self-report cognitive function scales.

Original languageEnglish (US)
Pages (from-to)551-559
Number of pages9
JournalQuality of Life Research
Volume7
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Virus Diseases
Cognition
Outcome Assessment (Health Care)
HIV
Trail Making Test
Depression
Disease Progression
CD4 Lymphocyte Count
Self Report
Epidemiologic Studies
Chronic Disease
Quality of Life

Keywords

  • Construct validity
  • HIV disease
  • MOS cognitive function scale
  • Psychometric characteristics

ASJC Scopus subject areas

  • Rehabilitation
  • Nursing(all)

Cite this

Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients. / Revicki, D. A.; Chan, K.; Gevirtz, F.

In: Quality of Life Research, Vol. 7, No. 6, 1998, p. 551-559.

Research output: Contribution to journalArticle

Revicki, D. A. ; Chan, K. ; Gevirtz, F. / Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients. In: Quality of Life Research. 1998 ; Vol. 7, No. 6. pp. 551-559.
@article{052bafcd7ea64271b9f0beb7fbb20463,
title = "Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients",
abstract = "Human immunodeficiency virus (HIV) infection results in a chronic course of disease progression and eventual death. With this disease progression comes decreases in health-related quality of life and cognitive function in many patients. We evaluated the construct and discriminant validity of the Medical Outcomes Study four-item and six-item cognitive function scale in a sample of 162 patients with HIV disease. The patients were assessed at baseline and after 4 months with the cognitive function scale, a cognitive functioning transition item, the Reitan trail making test (TMT) and the Centers for Epidemiologic Studies Depression (CES-D) scale. The results found that the four- and six-item cognitive function scales varied by HIV disease stage, CD4 count, self-reported change in cognitive function, TMT-based cognitive impairment and depression. The differences in the cognitive function scores were attenuated, but still remained statistically significant even after controlling for depression. The cognitive function scales predict cognitive impairment based on the TMT. The results support the construct validity of these self-report cognitive function scales.",
keywords = "Construct validity, HIV disease, MOS cognitive function scale, Psychometric characteristics",
author = "Revicki, {D. A.} and K. Chan and F. Gevirtz",
year = "1998",
doi = "10.1023/A:1008866122441",
language = "English (US)",
volume = "7",
pages = "551--559",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients

AU - Revicki, D. A.

AU - Chan, K.

AU - Gevirtz, F.

PY - 1998

Y1 - 1998

N2 - Human immunodeficiency virus (HIV) infection results in a chronic course of disease progression and eventual death. With this disease progression comes decreases in health-related quality of life and cognitive function in many patients. We evaluated the construct and discriminant validity of the Medical Outcomes Study four-item and six-item cognitive function scale in a sample of 162 patients with HIV disease. The patients were assessed at baseline and after 4 months with the cognitive function scale, a cognitive functioning transition item, the Reitan trail making test (TMT) and the Centers for Epidemiologic Studies Depression (CES-D) scale. The results found that the four- and six-item cognitive function scales varied by HIV disease stage, CD4 count, self-reported change in cognitive function, TMT-based cognitive impairment and depression. The differences in the cognitive function scores were attenuated, but still remained statistically significant even after controlling for depression. The cognitive function scales predict cognitive impairment based on the TMT. The results support the construct validity of these self-report cognitive function scales.

AB - Human immunodeficiency virus (HIV) infection results in a chronic course of disease progression and eventual death. With this disease progression comes decreases in health-related quality of life and cognitive function in many patients. We evaluated the construct and discriminant validity of the Medical Outcomes Study four-item and six-item cognitive function scale in a sample of 162 patients with HIV disease. The patients were assessed at baseline and after 4 months with the cognitive function scale, a cognitive functioning transition item, the Reitan trail making test (TMT) and the Centers for Epidemiologic Studies Depression (CES-D) scale. The results found that the four- and six-item cognitive function scales varied by HIV disease stage, CD4 count, self-reported change in cognitive function, TMT-based cognitive impairment and depression. The differences in the cognitive function scores were attenuated, but still remained statistically significant even after controlling for depression. The cognitive function scales predict cognitive impairment based on the TMT. The results support the construct validity of these self-report cognitive function scales.

KW - Construct validity

KW - HIV disease

KW - MOS cognitive function scale

KW - Psychometric characteristics

UR - http://www.scopus.com/inward/record.url?scp=0031667227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031667227&partnerID=8YFLogxK

U2 - 10.1023/A:1008866122441

DO - 10.1023/A:1008866122441

M3 - Article

C2 - 9737145

AN - SCOPUS:0031667227

VL - 7

SP - 551

EP - 559

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 6

ER -